RT Journal Article SR Electronic T1 Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: the beginning of a new era? JF European Respiratory Journal JO Eur Respir J FD European Respiratory Society SP 2102103 DO 10.1183/13993003.02103-2021 VO 60 IS 2 A1 Daniela Riccardi A1 Jeremy P.T. Ward A1 Polina L. Yarova A1 Luke J. Janssen A1 Tak Hong Lee A1 Sun Ying A1 Chris J. Corrigan YR 2022 UL http://erj.ersjournals.com/content/60/2/2102103.abstract AB In this review article we present the evidence to date supporting the role of the calcium-sensing receptor (CaSR) as a key, pluripotential molecular trigger for asthma and speculate on the likely benefits of topical therapy of asthma with negative allosteric modulators of the CaSR: calcilytics.Negative allosteric modulators of the calcium-sensing receptor (calcilytics) delivered topically to the airways have the potential to revolutionise asthma therapy https://bit.ly/3tdSZkC